Linklaters Advises On Tempsens Instruments’ IPO In India.

India’s New Draft Patent Manual: A Welcome Step Toward Greater Clarity and Predictability.

- Manisha Singh - Lex Orbis,

Linklaters Advises Porsche AG On The Sale Of MHP Management And IT-Beratung GmbH.

India – The Connected-Vehicle Audit Mandate: Securing Firmware, Telematics And FOTA Loops Across Auto Supply Chains.

India – Enforcement Vs. Due Process: Lessons From The FDA–Cadila Matter On Drug Regulation In Maharashtra.

India – A New Chapter In Settlement Regime: A Closer Look At The Draft Settlement Regulations, 2026.

India – The Mines And Minerals (Development And Regulation) Amendment Bill, 2026: Key Changes And Implications.

India – ESOP Buy-Backs Under The Taxman’s Lens.

India – Refusal Of Pharmaceutical Combination Patent Application Set Aside By Delhi High Court.

- DPS Parmar - Lex Orbis,

India – Pet Appetite And Weight-Loss Drug Survives Patent Rejection: Madras High Court Finds Refusal Order Arbitrary.

- DPS Parmar - Lex Orbis,

India – The Independent Record: Why Commercial Intent Now Needs An Evidentiary Architecture.

India – Analysing The MSME Development (Amendment) Bill, 2026: Proposed Changes To Registration, Delayed Payments And Dispute Resolution.

- Manisha Singh - Lex Orbis,